These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2109430)

  • 1. The disposition of tert-butyl-D-serine in the rat.
    Knott S; Warrander A; Phillips PJ; Harding JR
    Xenobiotica; 1990 Jan; 20(1):1-5. PubMed ID: 2109430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H NMR pattern recognition and 31P NMR studies with d-Serine in rat urine and kidney, time- and dose-related metabolic effects.
    Williams RE; Jacobsen M; Lock EA
    Chem Res Toxicol; 2003 Oct; 16(10):1207-16. PubMed ID: 14565762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography/mass spectrometry.
    Bernauer U; Amberg A; Scheutzow D; Dekant W
    Chem Res Toxicol; 1998 Jun; 11(6):651-8. PubMed ID: 9625733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach.
    Williams RE; Major H; Lock EA; Lenz EM; Wilson ID
    Toxicology; 2005 Feb; 207(2):179-90. PubMed ID: 15596249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the in vivo interaction of methyl tert-butyl ether with alpha2u-globulin in male F-344 rats.
    Prescott-Mathews JS; Poet TS; Borghoff SJ
    Toxicol Appl Pharmacol; 1999 May; 157(1):60-7. PubMed ID: 10329508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and disposition of n-butyl acrylate in male Fischer rats.
    Sanders JM; Burka LT; Matthews HB
    Drug Metab Dispos; 1988; 16(3):429-34. PubMed ID: 2900736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats.
    Myers SR; Spinnato JA
    Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat.
    Williams RE; Lock EA
    Toxicology; 2005 Feb; 207(1):35-48. PubMed ID: 15590120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of a novel antineoplastic agent, 4-tert-butyl-[3-(2-chloroethyl)ureido]benzene, in mice.
    Maurizis JC; Rapp M; Azim EM; Gaudreault RC; Veyre A; Madelmont JC
    Drug Metab Dispos; 1998 Feb; 26(2):146-51. PubMed ID: 9456301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats.
    Johnson KA; Prakash C
    Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of [14C]- and [35S]S-(1,2-dichlorovinyl)-L-cysteine in the male Fischer 344 rat.
    Finkelstein MB; Patel NJ; Anders MW
    Drug Metab Dispos; 1995 Jan; 23(1):124-8. PubMed ID: 7720515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of 14C-acetohydroxamic acid and 14C-acetamide in the rat.
    Putcha L; Griffith DP; Feldman S
    Drug Metab Dispos; 1984; 12(4):438-43. PubMed ID: 6148210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and metabolite pattern of clenbuterol in the rat].
    Kopitar Z; Zimmer A
    Arzneimittelforschung; 1976; 26(7a):1435-41. PubMed ID: 1036935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of 2,4-dinitroaniline in the male F-344 rat.
    Matthews HB; Chopade HM; Smith RW; Burka LT
    Xenobiotica; 1986 Jan; 16(1):1-10. PubMed ID: 3946093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.